A 14 week, randomized, double-blind, placebo-controlled trial of pregabalin twice daily in patients with fibromyalgia
Latest Information Update: 12 Feb 2021
Price :
$35 *
At a glance
- Drugs Pregabalin (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- Sponsors Pfizer
- 14 May 2016 Results of a pooled analysis from NCT00645398, NCT00230776, NCT00333866 trials (n=2228) presented at the 35th Annual Scientific Meeting of the American Pain Society
- 03 May 2014 Results from a pooled analysis presented at the 33rd Annual Scientific Meeting of the American Pain Society.
- 24 Sep 2008 Actual patient number changed from 986 to 755 as reported by ClinicalTrials.gov.